The Exploration – Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the MS research field. The studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation.
Proposals must address the treatment of MS Symptoms, which may include: Pain, Fatigue, Cognitive Dysfunction, Visual Impairment, Motor Impairment, Impaired Mobility, Loss of Bladder Control, Sexual Dysfunction, Depression, and Anxiety.
Funding & Duration
The maximum period of performance is 2 years. The anticipated direct costs budgeted for the entire period of performance will not exceed US $150,000 (approx AUD $193,000).
Funding may be used for salary, research supplies, clinical research costs, travel between collaborating organisations, travel costs for up to 1 investigator to travel to 1 scientific/technical meeting per year.
Preclinical research studies are not eligible for funding.
Primary Investigators (PIs) must be independent investigators at or above the level of Assistant Professor (or equivalent).
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Submission Requirements & Due Dates
- 26 May 2016 – pre-proposal submitted via https://eBRAP.org.
- Copy of pre-proposal forwarded to the Research Branch ASAP.
- 15 August 2016 – full applications (by invitation only) submitted to the Research Branch for internal review.
- Grants Officer: Dr Don McMaster
- Email: email@example.com